A 39-year-old male with follicular non-Hodgkin's lymphoma was repeatedly studied with respect to D N A rearrangements with the two probes pFL-I and pFL-2, representing two segments of chromosome 18. The oncogene BCL2, detected by pFL-I, was as expected translocated to the J region of the immunoglobu
Structural Alterations in the 5′ Region of the BCL2 Gene in Follicular Lymphomas With BCL2-MBR or BCL2-MCR Rearrangements
✍ Scribed by Vasiliki Mikraki; Marc Ladanyi; Dr. R. S. K. Chaganti
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 698 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
We report a new class of molecular lesions in the 5' region of the BCL2 protooncogene when it undergoes a t( 14; 18) translocation-associated rearrangement in the major break cluster (MBR) or minor break cluster (MCR) regions. Among 52 tumors assayed for BCL2 rearrangements using the MBR, MCR, and 5' probes, seven (six with MBR and one with MCR translocation breaks) showed aberrant bands in unique enzyme digests of D N A hybridized with the 5' probe. The aberrant bands in four tumors were in Hindlll digests, in two they were in EcoRl digests, while the aberrant band in one was in a B m H l digest. The two EcoRl bands and two of the four Hindlll bands were of identical sizes. Germline polymorphisms as the source of these bands was ruled out by appropriate control experiments. These results suggest that the bands were derived from point mutations or small deletions in the 5' region of BCL2. The significance of this alteration to BCU function in translocationcarrying tumors remains to be determined.
📜 SIMILAR VOLUMES
The nature of the bcl-2 family of protooncogenes was analyzed by sequence alignment, secondary structure prediction, and phylogenetic techniques. Phylogenies were inferred from both the nucleic acid and amino acid sequences of the human, murine, rat, and chicken sequences for BCL-2 and BCL-X, human
## Abstract Previous studies from our laboratory and others have suggested that increased expression of __cox‐2__ is important in the genesis of esophageal adenocarcinoma. __In vitro__ studies suggest that __cox‐2__ regulates expression of the anti‐apoptotic protein bcl‐2, thus possibly accounting